Barely Significant
← all excerpts

The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study.

Cells · 2024 · PMC10931172 · PMID 38474332

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

a notable trendp < 0.001actually significant
Among the activators of CDK1, cyclin A exhibited higher expression levels (compared to those of the other activator cyclin B2) with a notable trend of increased expression in CP-resistant cells (NT2/D1-R: +370.9%, p < 0.001; NCCIT-R: +117.2%, p < 0.05).

also in 731 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.